Skip to content
healthcare.dev

Sildenafil

NDC 51655-172, Sildenafil, tablet, from Northwind Health Company, LLC.

Product NDC
51655-172
Status
Listed
Labeler
Northwind Health Company, LLC
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA202025
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/51655-172 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • SILDENAFIL CITRATE20 mg/1

Pharmacologic classes

Phosphodiesterase 5 Inhibitor [EPC]; Phosphodiesterase 5 Inhibitors [MoA]

Package NDCNDC-11Package
51655-172-205165501722020 TABLET in 1 BOTTLE, PLASTIC (51655-172-20)
51655-172-525165501725230 TABLET in 1 BOTTLE, PLASTIC (51655-172-52)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/fa14cb6b-0fa8-0ba0-e053-6294a90afae3

Use it

Look up 51655-172 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/51655-172 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 51655-172. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.